Published in J Mol Med (Berl) on May 13, 2003
Gliadin peptides activate blood monocytes from patients with celiac disease. J Clin Immunol (2007) 1.24
Potential celiac patients: a model of celiac disease pathogenesis. PLoS One (2011) 0.99
PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage. Mol Med (2010) 0.94
Bifidobacterium longum CECT 7347 modulates immune responses in a gliadin-induced enteropathy animal model. PLoS One (2012) 0.92
Celiac disease, inflammation and oxidative damage: a nutrigenetic approach. Nutrients (2012) 0.92
Does hemochromatosis predispose to celiac disease? A study of 29,096 celiac disease patients. Scand J Gastroenterol (2012) 0.85
Immunological indicators of coeliac disease activity are not altered by long-term oats challenge. Clin Exp Immunol (2013) 0.85
Gliadin peptides induce tissue transglutaminase activation and ER-stress through Ca2+ mobilization in Caco-2 cells. PLoS One (2012) 0.84
Effect of anti-gliadin IgY antibody on epithelial intestinal integrity and inflammatory response induced by gliadin. BMC Immunol (2015) 0.81
Gene expression profile of peripheral blood monocytes: a step towards the molecular diagnosis of celiac disease? PLoS One (2013) 0.80
Intestinal stem cells and celiac disease. World J Stem Cells (2014) 0.78
Gene Expression Profiling of Gliadin Effects on Intestinal Epithelial Cells Suggests Novel Non-Enzymatic Functions of Pepsin and Trypsin. PLoS One (2013) 0.78
Identification and molecular characterization of oat peptides implicated on coeliac immune response. Food Nutr Res (2016) 0.77
Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease. J Transl Med (2015) 0.76
The AhR and NF-κB/Rel Proteins Mediate the Inhibitory Effect of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin on the 3' Immunoglobulin Heavy Chain Regulatory Region. Toxicol Sci (2015) 0.75
Cytoplasmic Form of Carlr lncRNA Facilitates Inflammatory Gene Expression upon NF-κB Activation. J Immunol (2017) 0.75
Multiple common variants for celiac disease influencing immune gene expression. Nat Genet (2010) 6.90
Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet (2011) 6.36
Regulation of autophagy by cytoplasmic p53. Nat Cell Biol (2008) 5.97
HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol (2003) 3.17
Stimulation of autophagy by the p53 target gene Sestrin2. Cell Cycle (2009) 2.72
Natural history of potential celiac disease in children. Clin Gastroenterol Hepatol (2010) 2.55
The IKK complex contributes to the induction of autophagy. EMBO J (2009) 2.41
Randomized feeding intervention in infants at high risk for celiac disease. N Engl J Med (2014) 2.39
Formula selection for management of children with cow's milk allergy influences the rate of acquisition of tolerance: a prospective multicenter study. J Pediatr (2013) 2.08
Effect of Lactobacillus GG on tolerance acquisition in infants with cow's milk allergy: a randomized trial. J Allergy Clin Immunol (2011) 1.97
Functional gastrointestinal disorders in children: an Italian prospective survey. Pediatrics (2004) 1.89
Clinical, HLA, and small bowel immunohistochemical features of children with positive serum antiendomysium antibodies and architecturally normal small intestinal mucosa. Am J Gastroenterol (2005) 1.80
An Italian prospective multicenter survey on patients suspected of having non-celiac gluten sensitivity. BMC Med (2014) 1.65
Gluten sensitivity in a subset of children with insulin dependent diabetes mellitus. Am J Gastroenterol (2003) 1.65
Intestinal deposits of anti-tissue transglutaminase IgA in childhood celiac disease. Dig Liver Dis (2011) 1.59
Evidence of still-ongoing convergence evolution of the lactase persistence T-13910 alleles in humans. Am J Hum Genet (2007) 1.51
Paediatric conferences: only a profit making enterprise? Acta Paediatr (2012) 1.41
In vitro-deranged intestinal immune response to gliadin in type 1 diabetes. Diabetes (2004) 1.41
Genetics in coeliac disease. Best Pract Res Clin Gastroenterol (2005) 1.37
World Gastroenterology Organisation global guidelines on celiac disease. J Clin Gastroenterol (2013) 1.29
Celiac disease: predictors of compliance with a gluten-free diet in adolescents and young adults. J Pediatr Gastroenterol Nutr (2010) 1.28
Diagnosis and Rationale for Action Against Cow's Milk Allergy (DRACMA): a summary report. J Allergy Clin Immunol (2010) 1.24
Combined use of noninvasive tests is useful in the initial diagnostic approach to a child with suspected inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2006) 1.20
Celiac disease in type 1 diabetes mellitus. Ital J Pediatr (2012) 1.19
Sourdough bread made from wheat and nontoxic flours and started with selected lactobacilli is tolerated in celiac sprue patients. Appl Environ Microbiol (2004) 1.17
HLA related genetic risk for coeliac disease. Gut (2007) 1.16
Gliadin activates HLA class I-restricted CD8+ T cells in celiac disease intestinal mucosa and induces the enterocyte apoptosis. Gastroenterology (2008) 1.15
Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease. Gastroenterology (2007) 1.14
Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease. J Immunol (2009) 1.14
Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy. J Pediatr Gastroenterol Nutr (2008) 1.13
Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement. Neurosci Lett (2006) 1.13
Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease. Am J Gastroenterol (2003) 1.13
Growth factor-like activity of gliadin, an alimentary protein: implications for coeliac disease. Gut (2006) 1.12
Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study. J Pediatr (2010) 1.10
Significant factors associated with fatal outcome in emergency open surgery for perforated peptic ulcer. World J Gastroenterol (2003) 1.09
Management of mucinous cystic neoplasms of the pancreas. World J Gastroenterol (2010) 1.09
Targeting autophagy as a novel strategy for facilitating the therapeutic action of potentiators on ΔF508 cystic fibrosis transmembrane conductance regulator. Autophagy (2012) 1.08
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease. Gastroenterology (2007) 1.08
IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in Celiac disease. Am J Gastroenterol (2011) 1.04
Brain and spine MRI features of Hunter disease: frequency, natural evolution and response to therapy. J Inherit Metab Dis (2011) 1.03
Safety for patients with celiac disease of baked goods made of wheat flour hydrolyzed during food processing. Clin Gastroenterol Hepatol (2010) 1.02
Gliadin regulates the NK-dendritic cell cross-talk by HLA-E surface stabilization. J Immunol (2007) 1.02
Adaptive and innate immune responses in celiac disease. Immunol Lett (2005) 1.01
Management of descending duodenal injuries secondary to laparoscopic cholecystectomy. Dig Surg (2008) 1.01
Gliadin-specific type 1 regulatory T cells from the intestinal mucosa of treated celiac patients inhibit pathogenic T cells. J Immunol (2006) 1.00
Macrophage autophagy in atherosclerosis. Mediators Inflamm (2013) 1.00
Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide. J Cell Mol Med (2011) 0.99
Evaluation of Italian patients with leber congenital amaurosis due to AIPL1 mutations highlights the potential applicability of gene therapy. Invest Ophthalmol Vis Sci (2011) 0.99
Molecular and clinical characterization of albinism in a large cohort of Italian patients. Invest Ophthalmol Vis Sci (2011) 0.99
The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells. J Mol Med (Berl) (2005) 0.99
Potential celiac patients: a model of celiac disease pathogenesis. PLoS One (2011) 0.99
Celiac disease association with CD8+ T cell responses: identification of a novel gliadin-derived HLA-A2-restricted epitope. J Immunol (2003) 0.98
Butyrate as an effective treatment of congenital chloride diarrhea. Gastroenterology (2004) 0.98
Antibacterial and antioxidant activities of ethanol extract from Paullinia cupana Mart. J Ethnopharmacol (2005) 0.97
Gliadin-mediated proliferation and innate immune activation in celiac disease are due to alterations in vesicular trafficking. PLoS One (2011) 0.96
Gliadin peptide P31-43 localises to endocytic vesicles and interferes with their maturation. PLoS One (2010) 0.96
MicroRNA-449a overexpression, reduced NOTCH1 signals and scarce goblet cells characterize the small intestine of celiac patients. PLoS One (2011) 0.95
Neutralization of interleukin-18 inhibits neointimal formation in a rat model of vascular injury. Circulation (2006) 0.94
Kocuria kristinae endocarditis related to diabetic foot infection. J Med Microbiol (2013) 0.94
Rotavirus and celiac disease: clues to the pathogenesis and perspectives on prevention. J Pediatr Gastroenterol Nutr (2007) 0.93
Immunogenicity of monococcum wheat in celiac patients. Am J Clin Nutr (2012) 0.93
IKK connects autophagy to major stress pathways. Autophagy (2010) 0.92
Serum and intestinal celiac disease-associated antibodies in children with celiac disease younger than 2 years of age. J Pediatr Gastroenterol Nutr (2010) 0.92
A functional soluble form of CTLA-4 is present in the serum of celiac patients and correlates with mucosal injury. Int Immunol (2009) 0.92
Molecular analysis of NPC1 and NPC2 gene in 34 Niemann-Pick C Italian patients: identification and structural modeling of novel mutations. Neurogenetics (2009) 0.92
Celiac disease: Working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr (2002) 0.91
Gluten Introduction and the Risk of Coeliac Disease: A Position Paper by the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr (2016) 0.91
The role of NF-kappaB, IRF-1, and STAT-1alpha transcription factors in the iNOS gene induction by gliadin and IFN-gamma in RAW 264.7 macrophages. J Mol Med (Berl) (2005) 0.91
Meta and pooled analysis of European coeliac disease data. Eur J Hum Genet (2003) 0.91
The PreventCD Study design: towards new strategies for the prevention of coeliac disease. Eur J Gastroenterol Hepatol (2010) 0.90
Immunogenicity of two oat varieties, in relation to their safety for celiac patients. Scand J Gastroenterol (2011) 0.90
Latest developments in the pathogenesis and treatment of celiac disease. J Pediatr (2006) 0.89
The I{kappa}B kinase inhibitor nuclear factor-{kappa}B essential modulator-binding domain peptide for inhibition of injury-induced neointimal formation. Arterioscler Thromb Vasc Biol (2010) 0.89
Markers of potential coeliac disease in patients with Hashimoto's thyroiditis. Eur J Endocrinol (2002) 0.89
Fine mapping of the celiac disease-associated LPP locus reveals a potential functional variant. Hum Mol Genet (2013) 0.89
An undigested gliadin peptide activates innate immunity and proliferative signaling in enterocytes: the role in celiac disease. Am J Clin Nutr (2013) 0.88
NFkappaB decoy oligonucleotides. Curr Opin Mol Ther (2010) 0.88
Potential celiac disease in type 1 diabetes: a multicenter study. Diabetes Res Clin Pract (2011) 0.88
Obesity duration is associated to pulmonary function impairment in obese subjects. Obesity (Silver Spring) (2011) 0.88
Constitutive activation of the signal transducer and activator of transcription pathway in celiac disease lesions. Am J Pathol (2003) 0.87
Italian paediatricians' approach to coeliac disease diagnosis. J Pediatr Gastroenterol Nutr (2009) 0.86
Oligonucleotide decoy to NF-kappaB slowly released from PLGA microspheres reduces chronic inflammation in rat. Pharmacol Res (2009) 0.86
Lycopene, quercetin and tyrosol prevent macrophage activation induced by gliadin and IFN-gamma. Eur J Pharmacol (2007) 0.86
Novel cationic liposome formulation for the delivery of an oligonucleotide decoy to NF-kappaB into activated macrophages. Eur J Pharm Biopharm (2008) 0.85
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells. Biochim Biophys Acta (2010) 0.85
Effects of disease activity on anti-Saccharomyces cerevisiae antibodies: implications for diagnosis and follow-up of children with Crohn's disease. Inflamm Bowel Dis (2004) 0.85
Nuclear factor-kappaB regulates inflammatory cell apoptosis and phagocytosis in rat carrageenin-sponge implant model. Am J Pathol (2004) 0.85
The diagnosis of food allergy in children. Curr Opin Pediatr (2008) 0.85